MetS is associated with elevated inflammatory biomarkers such as TNF-α, CRP, and interleukins (known as IL-1β, IL-4, IL-6, and IL-10) and were considered in the development of the DII [10]. The gene discussed is IL10; the disease is metabolic syndrome.